(VIANEWS) – OCI (OCI.AS), CAMBODGE NOM. (CBDG.PA), VEIDEKKE (VEI.OL) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio up to now. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. OCI (OCI.AS)
839.31% Payout Ratio
OCI N.V. produces and distributes hydrogen-based and natural gas-based products to agricultural, transportation, and industrial customers. It operates through Methanol US, Methanol Europe, Nitrogen US, Nitrogen Europe, and Fertiglobe segments. The company offers anhydrous ammonia, granular urea, urea ammonium nitrate solution, calcium ammonium nitrate, ammonium sulphate, aqueous ammonia, nitric acid, urea solution, bio-methanol, methanol, melamine, and diesel exhaust fluid, as well as other nitrogen products. It also owns and operates an ammonia terminal at the port of Rotterdam. The company has operations in Europe, the Americas, the Middle East, Africa, Asia, and Oceania. OCI N.V. has a strategic partnership with Abu Dhabi National Oil Company. OCI N.V. was founded in 2013 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, OCI has a trailing twelve months EPS of €-1.08.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.32%.
Moving Average
OCI’s value is way higher than its 50-day moving average of €23.22 and way higher than its 200-day moving average of €23.47.
More news about OCI.
2. CAMBODGE NOM. (CBDG.PA)
494.51% Payout Ratio
Compagnie du Cambodge, together with its subsidiaries, provides transportation and logistics services in France. It operates a railway concession linking Burkina Faso with Ivory Coast. The company was incorporated in 1998 and is headquartered in Puteaux, France. Compagnie du Cambodge is a subsidiary of Plantations Des Terres Rouges S.A.
Earnings Per Share
As for profitability, CAMBODGE NOM. has a trailing twelve months EPS of €36.18.
PE Ratio
CAMBODGE NOM. has a trailing twelve months price to earnings ratio of 187.95. Meaning, the purchaser of the share is investing €187.95 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.52%.
More news about CAMBODGE NOM..
3. VEIDEKKE (VEI.OL)
96.88% Payout Ratio
Veidekke ASA operates as a construction and property development company. It operates through Construction Norway, Infrastructure Norway, Construction Sweden, Infrastructure Sweden, and Denmark/Hoffmann segments. The company operates as a construction contractor; executes civil engineering and renovation projects; and produces asphalt and aggregates, as well as operates in the public road maintenance market. It is also involved in the civil engineering, recycling, and asphalting projects, as well as constructs commercial and residential buildings. Veidekke ASA was founded in 1936 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VEIDEKKE has a trailing twelve months EPS of kr8.
PE Ratio
VEIDEKKE has a trailing twelve months price to earnings ratio of 12.09. Meaning, the purchaser of the share is investing kr12.09 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 44.7%.
Volume
Today’s last reported volume for VEIDEKKE is 19456 which is 71.39% below its average volume of 68025.
Earnings Before Interest, Taxes, Depreciation, and Amortization
VEIDEKKE’s EBITDA is 13.59.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.8%, now sitting on 41.85B for the twelve trailing months.
More news about VEIDEKKE.
4. IBA (IBAB.BR)
94.67% Payout Ratio
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
Earnings Per Share
As for profitability, IBA has a trailing twelve months EPS of €-0.68.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.17%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 29, 2023, the estimated forward annual dividend rate is 0.21 and the estimated forward annual dividend yield is 2%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.9%, now sitting on 370.66M for the twelve trailing months.
Volume
Today’s last reported volume for IBA is 7649 which is 69.51% below its average volume of 25092.
Moving Average
IBA’s value is below its 50-day moving average of €10.95 and way below its 200-day moving average of €12.56.
More news about IBA.
5. UCB (UCB.BR)
78.24% Payout Ratio
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition, the company is involved in developing rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis and immune-mediated necrotizing myopathy; staccato alprazolam to treat tereotypical prolonged seizure; Bepranemab to treat Alzheimer's disease; and UCB0599 to treat Parkinson's disease. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, Otsuka, and doc.ai. It operates in the United States, Japan, Germany, rest of Europe, Spain, France, China, Italy, the United Kingdom, Ireland, Belgium, and internationally. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UCB has a trailing twelve months EPS of €1.7.
PE Ratio
UCB has a trailing twelve months price to earnings ratio of 50.72. Meaning, the purchaser of the share is investing €50.72 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.7%.
Moving Average
UCB’s worth is way higher than its 50-day moving average of €76.85 and above its 200-day moving average of €79.58.
Yearly Top and Bottom Value
UCB’s stock is valued at €86.22 at 16:10 EST, under its 52-week high of €88.80 and way above its 52-week low of €65.40.
Revenue Growth
Year-on-year quarterly revenue growth declined by 11.8%, now sitting on 5.11B for the twelve trailing months.
Volume
Today’s last reported volume for UCB is 21899 which is 93.28% below its average volume of 325963.
More news about UCB.
6. GRAM CAR CARRIERS (GCC.OL)
44.17% Payout Ratio
Gram Car Carriers ASA, through its subsidiaries, operates as a tonnage supplier worldwide. The company invests in and operates assets in the pure car and truck carrier shipping segment. It also offers commercial management services for the 19 owned carriers and 1 vessel managed by third party. The company was founded in 2006 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, GRAM CAR CARRIERS has a trailing twelve months EPS of kr22.77.
PE Ratio
GRAM CAR CARRIERS has a trailing twelve months price to earnings ratio of 9.88. Meaning, the purchaser of the share is investing kr9.88 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.53%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 72% and positive 151.2% for the next.
Yearly Top and Bottom Value
GRAM CAR CARRIERS’s stock is valued at kr225.00 at 16:10 EST, under its 52-week high of kr234.50 and way above its 52-week low of kr135.20.
More news about GRAM CAR CARRIERS.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1%, now sitting on 1 for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
1’s EBITDA is 1.
Volume
Today’s last reported volume for 1 is 1 which is 1% above its average volume of 1.
More news about 1.
